Drug firms suffer in China over GlaxoSmithKline bribery probe

Sales of GlaxoSmithKline (GSK) and other drug firms have suffered from the mainland investigation of suspected corruption at the British firm and other drug multinationals, GSK chief executive Andrew Witty said yesterday.

via Business feed http://www.scmp.com/business/companies/article/1338300/drug-firms-suffer-china-over-glaxosmithkline-bribery-probe